Previous 10 | Next 10 |
BD Acquires Scanwell Health, Inc. to Expand and Scale Digital At-Home Testing Advances company's innovation focus on enabling new care settings and accelerating smart connected care PR Newswire FRANKLIN LAKES, N.J. , Dec. 21, 2021 /PRNewswire/ -- BD (Bec...
BD Expands Fully Automated High-Throughput Molecular Diagnostic Platform for Core Labs BD COR™ MX for Infectious Disease Testing Receives CE Mark and is Final Instrument Introduced on BD COR™ System PR Newswire FRANKLIN LAKES, N.J. , Dec. 17, 2021...
Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This report optimizes tradi...
We review 5 top stock ideas that have been created by the Fed’s tomfoolery (3 are pure-growth stocks and 2 are dividend-growth stocks). We also discuss a big reason why cryptocurrency popularity continues to grow (hint: more Fed tomfoolery). We conclude with our opinion on ...
Tissuemed develops and markets adhesive films to prevent air, blood, and fluid leaks encountered in surgery. The commercial terms were not disclosed. Tissuemed's lead product, Tissuepatch™, is a proprietary sealant technology that bonds to tissue to help control internal bleeding or pr...
BD Acquires Tissuemed, Ltd. To Add Advanced Sealant To Its Portfolio Of Surgical Solutions - Acquisition complements BD's core portfolio - adding an innovative, broadly applicable surgical sealant to a suite of BD biosurgery products already relied upon in the operating room. ...
The 32 Dividend Kings lost 1.68% in November, underperforming the broad market once more this year. The 8 best dividend kings based on forecasted growth and valuation offered 36 bps of alpha in November. Since July, the buy and hold portfolio for this strategy has gained 528 bps o...
Piper Sandler analyst Jason Bednar has downgraded Becton Dickinson (NYSE:BDX) to Neutral from Overweight with a price target (PT) of $260, down from $285. Shares down 1.3% premarket at $247.05. The analyst sees a lack of catalysts for shares over at least the next six months along w...
We provide a summary of upcoming ex-dividend dates in a quick reference table. The table includes relevant data and key statistics as well as the next payout and pay date. We highlight a high-quality stock with an upcoming ex-dividend date for further research and possible investm...
Becton, Dickinson, and Company (NYSE:BDX) has selected "embecta" as the name for its Diabetes Care business which will become an independent, publicly-traded company after the completion of its previously announced spinoff. Post-spinoff, embecta will be led by CEO Devdatt (Dev) Kurdikar, as p...
News, Short Squeeze, Breakout and More Instantly...
Becton Dickinson and Company Company Name:
BDX Stock Symbol:
NYSE Market:
Becton Dickinson and Company Website:
BD, Quest Diagnostics Join Forces to Develop Companion Diagnostics for Cancer, Other Diseases PR Newswire Collaboration on Flow Cytometry-Based Companion Diagnostics to Advance Personalized Health Care FRANKLIN LAKES, N.J. and SECAUCUS, N.J. , July 25, 20...
2024-07-11 12:00:00 ET July 11, 2024 (Investorideas.com Newswire) Investorideas.com , a go-to investing platform releases the second of a two-part series looking at recent news and developments in the blood infections treatment market, featuring Citius Pharmaceuticals, Inc. ( Nasdaq:C...
BD Statement on Supplier Issue Impacting BD BACTEC™ Blood Culture Vials PR Newswire Company Committed to Support Global Health and Customers BD Taking all Available Measures to Mitigate Supplier Issue FRANKLIN LAKES, N.J. , July 10 , 2024...